Hormonal contraception and PMS. Inger Sundström Poromaa Department of Women s and Children s Health Uppsala University

Similar documents
Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder

Treatment of Mood Disorders in Midlife Women

Premenstrual dysphoric disorder (PMDD)

Placebo-Controlled Trial Comparing Intermittent and Continuous Paroxetine in Premenstrual Dysphoric Disorder

Daily Record of Severity of Problems (DRSP): reliability and validity

The term premenstrual disorders

Approximately 75% of women experience a premenstrual

Premenstrual Syndrome Latest Definitions, Management Guidelines & Research

MANAGEMENT OF PREMENSTRUAL DISORDERS

Women s Mental Health

Mental Health for Women s Health

Special Issues in Menopause and Major Depressive Disorder

Premenstrual Syndrome Management Options

Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A

Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A

Diagnosis, pathophysiology and management of premenstrual syndrome

Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol

Drug Surveillance 1.

5 COMMON QUESTIONS WHEN TREATING DEPRESSION

A Review of Treatment and Management Modalities for Premenstrual Dysphoric Disorder

Assessment and Management of Depression Over the Female Life Cycle

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objective: Primary Outcome/Efficacy Variable:

Mental Health and Women s Health

Effects of Antidepressants on Quality of Life in Women with Premenstrual Dysphoric Disorder

1 de 13 22/03/ :17 p.m.

Exploring New Treatment Options. case study on PMDD and the current recommendations for treatment. A Case Study on PMDD

Study No: Title: Rationale: . Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Premenstrual Syndrome

Oral contraceptives and premenstrual symptoms: Comparison of a 21/7 and extended regimen

Pattern of premenstrual symptoms among pre-clinical medical students at the University of Nigeria

Endocrinology, Menstrual cycle, Menopause and. Prof Bev Lawton (Anna Fenton) Centre for Women s Health Research Victoria Unversity Wellington

The biology of menstrually related. Ovulation Suppression of Premenstrual Symptoms Using Oral Contraceptives REPORTS. Patricia J.

Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review

23/05/18. Mood changes in postmenopausal women treated with progesterone

PMS / PMDD. Prof John Studd Imperial College London London PMS and Menopause Centre. www. studd.co.uk

Average dose zoloft for ocd and anxiety

Information for you. Managing premenstrual syndrome (PMS) What is PMS?

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objective: Primary Outcome/Efficacy Variable:

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment

Premenstrual Dysphoric Disorder

Numerous symptoms are commonly attributed to

Approach to Premenstrual Dysphoria for the Mental Health Practitioner

Management of a HIV-infected patient with a psychiatric disorder

PREMENSTRUAL SYNDROME: PREVALENCE IN STUDENTS OF THE UNIVERSITY OF CALABAR, NIGERIA

Premenstrual dysphoric disorder: current status of treatment

International Journal of Basic and Applied Physiology

Mar 6, The most effective medications are described in the next section. Selective serotonin reuptake inhibitors (SSRIs) SSRIs are a highly

Outline. Understanding Placebo Response in Psychiatry: The Good, The Bad, and The Ugly. Definitions

The New England Journal of Medicine

WHI Estrogen--Progestin vs. Placebo (Women with intact uterus)

Clinical Significance of Anxiety in Depressed Patients Selecting an Antidepressant

Mental Illness Through Menopause

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Information for you. Managing premenstrual syndrome (PMS) What is PMS?

Management of Perimenopausal symptoms

Gender-Specific Differences in Depression and Treatment Response

Objectives. Sexual dysfunction (SD) SD in the general population. Assessment of sexual functioning ANTIDEPRESSANT-INDUCED SEXUAL DYSFUNCTION

Premenstrual Syndrome

Assessment and Treatment of Depression in Menopause

Pharmacological treatment of anxiety disorders where is

PERIMENOPAUSAL. For personal use only. Copyright Dowden Health Media

Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises?

WHAT S NEW. Vilazodone (Viibryd ) Vilazodone - Dosing ANTIDEPRESSANT UPDATE: What s New? The Cardiac Debate The Efficacy Debate?Pharmacogenomics?

PSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust

Severe premenstrual syndrome (premenstrual dysphoric

Document Title Pharmacological Management of Generalised Anxiety Disorder

Supplementary Online Content

Relieving Premenstrual Syndrom Symptoms With Foot Reflexology as a Complementary Therapy Summary

Womens Early Years. Nayan Patel PharmD

Premenstrual Syndrome, Premenstrual Dysphoric Disorder, and Beyond: A Clinical Primer for Practitioners

Depression. University of Illinois at Chicago College of Nursing

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Mother May I? Managing Mental Illness During Pregnancy: Focus on Antidepressants

JMSCR Volume 03 Issue 04 Page April 2015

Antidepressant does not relieve repetitive behaviors

Degree of Premenstrual Mood Cyclicity is Predictive of Elevated Tonic Interleukin-6 Levels in Women with Menstrually-Related Mood Disorder

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

Depression & Anxiety in Adolescents

Department of Psychiatry & Behavioral Sciences. University of Texas Medical Branch

Treating treatment resistant depression

Postpartum Mood Disorders

Antidepressant Selection in Primary Care

September 26 28, 2013 Westin Tampa Harbour Island. Co-sponsored by

Antidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry

Start Low, Go Slow but Treat to Target

Hormone therapy for menopausal vasomotor symptoms

Severe premenstrual syndrome and bipolar disorder: a tragic confusion

Antidepressant tapering advice

Managing premenstrual syndrome (PMS)

Reviewing the long-term use of selective serotonin reuptake inhibitors in patients with depression

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

PRIMARY CARE PSYCHIATRY VOL. 9, NO. 1, 2003, 15 20

Suitable dose and duration of fluvoxamine administration to treat depression

Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Symptoms and Cluster Influences

Postpartum Depression. Deborah Kim, M.D. Assistant Professor Department of Psychiatry

Non hormonal medical treatment of vasomotor symptoms

Premenstrual Syndrome and Premenstrual Dysphoric Disorder

D I A G N O S I S ADD/ADHD. Conduct Disorder. Oppositional. Oppositional Defiant Disorder. Defiant. Anxiety Disorder. Adjustment.

Transcription:

Hormonal contraception and PMS Inger Sundström Poromaa Department of Women s and Children s Health Uppsala University

Definitions Premenstrual syndrome (PMS) ICD 10: Two symptoms, at least one psychological, regularly recurring in the premenstrual week Prevalence 17-18% Premenstrual dysphoric disorder (PMDD) DSM-5: Five symptom, at least four psychological, regularly recurring in the premenstrual week Prevalence 3% Treatment studies primarily done in PMDD

Prevalence of premenstrual symptoms

Progesterone causes the symptoms Mood symptoms with hormonal contraception Mood symptoms during sequential HRT resemble PMS GnRH agonists alleviate symptoms Progesterone treatment ineffective

RCTs on antidepressants Stone AB, et al. Fluoxetine. Psychopharmacol Bull. 1990; Veeninga AT, et al. Fluoxetine. Psychopharmacology (Berl). 1990; Stone AB et al. Fluoxetine. J Clin Psychiatry. 1991. Sundblad C et al. Clomipramine. Acta Psychiatr Scand. 1992 Wood SH et al. Fluoxetine. Obstet Gynecol. 1992 Sundblad C et al. Clomipramine. Neuropsychopharmacology. 1993 Eriksson E et al. Paroxetine. Neuropsychopharmacology. 1995. Steiner M et al. Fluoxetine. N Engl J Med. 1995 Halbreich U and Smoller JW. Sertraline. J Clin Psychiatry. 1997 Pearlstein TB et al. Fluoxetine,. J Clin Psychopharmacol. 1997 Su TP et al. Fluoxetine. Neuropsychopharmacology. 1997 Yonkers KA et al. Sertraline. JAMA. 1997 Wikander I et al. Citalopram. J Clin Psychopharmacol. 1998 Young SA et al. Sertraline. J Clin Psychiatry. 1998 Freeman EW et al. Fluoxetine. J Clin Psychopharmacol. 1999 Freeman EW et al. Fluoxetine. Arch Gen Psychiatry. 1999 Jermain DM et al. Sertraline. Arch Fam Med. 1999 Freeman EW et al. Venlafaxine. Obstet Gynecol. 2001 Cohen LS et al. Fluoxetine. Obstet Gynecol. 2002 Halbreich U et al. Sertraline. Obstet Gynecol. 2002 Hunter MS et al. Fluoxetine. J Psychosom Obstet Gynaecol. 2002 Miner C et al. Fluoxetine. Clin Ther. 2002 Cohen LS et al. Paroxetine. Psychosom Med. 2004 Freeman EW et al. Sertraline. Am J Psychiatry. 2004 Freeman EW et al. Escitalopram. J Clin Psychiatry. 2005 Steiner M et al. Paroxetine. Am J Obstet Gynecol. 2005 Yonkers KA et al. Sertraline. J Affect Disord. 2005 Kornstein SG et al. Sertraline. J Clin Psychiatry. 2006 Yonkers KA et al. Sertraline. J Clin Psychopharmacol. 2006 Landen M et al. Paroxetine. Neuropsychopharmacology. 2007. Eriksson E et al. Escitalopram. J Clin Psychopharmacol. 2008 Steiner M et al. Paroxetine. J Clin Psychiatry. 2008 Wu KY et al. Paroxetine. Psychiatry Clin Neurosci. 2008 Yonkers et al. Sertraline. JAMA Psychiatry. 2015

Antidepressant use in PMDS Higher response rate than in depression (60-90% responders) Response within 48 hours Cyclic treatment 10-14 days before menses All serotonergic antidepressants work chose the one you know

How about hormonal contraception? Combined oral contraceptives Mirena? Esmya?

Yasmin for PMS/PMDD Drosperinone similar to spironolactone 82 women with PMDD Placebo-controlled RCT Significant improvement in appetite, acne and food cravings Freeman, 2002.

YAZ and PMDD 2 placebo-controlled studies 328 PMDD women, parallel Improved with YAZ (24/4) Yonkers et al, Obstet Gynecol 2005 25 PMDD women, cross-over Improved with YAZ (24/4) Pearlstein et al, Contraception 2005

Cross-over study YAZ DRSP Sum Score 75 70 65 60 55 50 45 40 35 30 Baseline End of Treatment Period 1 End of Washout Phase End of Treatment Period 2 Group 1 - Placebo) (YAZ Group 2 (Placebo - YAZ) Pearlstein T et al. Contraception 2005;414-421

Parallel study - YAZ 0 depressed anxious mood swings angry less interest concentration lethargic appetite sleep out of control physical -1-2 -3-4 -5-6 -7 ** *** *** *** ** *** ** ** ** ** *** YAZ Placebo Kimberley A. et al, Obst & Gynecol 2005; Vol 106 :492-501

BUT the PMDD women often complain they cannot tolerate combined hormonal contraception

Placebo-controlled RCT in healthy women Lundin C, Danielsson KG, Bixo M, Moby L, Bengtsdotter H, Jawad I, Marions L, Brynhildsen J, Malmborg A, Lindh I, Sundstrom Poromaa I. Psychoneuroendocrinology. 2017;76:135-143.

Mirena? Leminen A et al. Acta Obstet Gynecol Scand 2012;91(3):318-25

Mifepristone? Halbreich U. Psychiatry. 1990 Nov;53(4):407-9.

Mifepristone? Two small published studies on single-dose mifepristone One unpublished study with positive results Some studies on high-dose mifepristone on psychotic depression

Esmya, ongoing trial in women with PMDD

Conclusion Low-dose 24/4 combined oral contraceptives can be used to treat PMDD Be ware of increased symptoms in the intermenstrual phase SSRI appear superior in the clinic but head-to-head comparisons are lacking